Leukocyte recruitment in the brain in sepsis: involvement of the annexin 1‐FPR2/ALX anti‐inflammatory system
The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Unregulated inflammation underlies many diseases, including sepsis. Much interest lies in targeting anti‐inflammatory mechanisms to develop new treatments. One such target is the anti‐inflammatory protein annexin A1 (AnxA1) and its receptor, FPR2/ALX. Using intravital videomicroscopy, we investigated the role of AnxA1 and FPR2/ALX in a murine model of endotoxin‐induced cerebral inflammation [intraperitoneal injection of lipopolysaccharide (LPS)]. An inflammatory response was confirmed by elevations in proinflammatory serum cytokines, increased cerebrovascular permeability, elevation in brain myeloperoxidase, and increased leukocyte rolling and adhesion in cerebral venules of wild‐type (WT) mice, which were further exacerbated in AnxA1‐null mice. mRNA expression of TLR2, TLR4, MyD‐88, and Ly96 was also assessed. The AnxA1‐mimetic peptide, AnxA1 Ac2 ‐ 2 6 (100 μg/mouse, ~33 μmol) mitigated LPS‐induced leukocyte adhesion in WT and AnxA1‐null animals without affecting leukocyte rolling, in comparison to saline control. AnxA1 Ac2‐26 effects were attenuated by Boc2 (pan‐FPR antagonist, 10 μg/mouse, ~12 nmol), and by minocycline (2.25 mg/mouse, ~6.3 nmol). The nonselective Fpr agonists, fMLP (6 μg/mouse, ~17 nmol) and AnxA1Ac2‐26, and the Fpr2‐selective agonist ATLa (5 μg/mouse, ~11 nmol) were without effect in Fpr2/3 –/– mice. In summary, our novel results demonstrate that the AnxA1/FPR2 system has an important role in effecting the resolution of cerebral inflammation in sepsis and may, therefore, provide a novel therapeutic target.—Gavins, F. N. E., Hughes, E. L., Buss, N. A. P. S., Holloway, P. M., Getting, S. J., Buckingham, J. C. Leukocyte recruitment in the brain in sepsis: involvement of the annexin 1‐FPR2/ALX anti‐inflammatory system. FASEB J. 26, 4977–4989 (2012). www.fasebj.org
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Resolution of inflammation: the beginning programs the end
Serhan, C. N., & Savill, J. (2005) · Nature Immunology · doi:10.1038/ni1276 · Cited by 2,552 · cited 1×
“However, despite these findings, the concept that acute inflammation resolves itself through an active process is still in its infancy (6, 50).”
BackgroundSystemic LPS causes chronic neuroinflammation and progressive neurodegeneration
Qin, L., Wu, X., Block, M. L., Liu, Y., Breese, G. R., Hong, J., Knapp, D. J., & Crews, F. T. (2007) · Glia · doi:10.1002/glia.20467 · Cited by 2,144 · cited 1×
“It is likely that the initial neuroinflammatory response is mediated by the increase in peripheral proinflammatory cytokines that can activate brain microglia (39), and the lack of increase in mRNA at 2 h suggests that the response is quite mild.”
BackgroundLipid mediator class switching during acute inflammation: signals in resolution
Levy, B. D., Clish, C. B., Schmidt, B., Gronert, K., & Serhan, C. N. (2001) · Nature Immunology · doi:10.1038/89759 · Cited by 1,453 · cited 3×
“Proinflammatory cytokines also activate microglial cells within the brain parenchyma (4), which stimulates further cytokine release (5) and initiates a vicious circle of cerebral inflammation (6).”
BackgroundHenry, C. J., Huang, Y., Wynne, A., Hanke, M., Himler, J., Bailey, M. T., Sheridan, J. F., & Godbout, J. P. (2008) · Journal of Neuroinflammation · doi:10.1186/1742-2094-5-15 · Cited by 678 · cited 1×
“Minocycline readily crosses the BBB and attenuates inflammation associated with microglial activation (45, 59).”
BackgroundIntracellular signaling in M‐CSF‐induced microglia activation: Role of Iba1
Imai, Y., & Kohsaka, S. (2002) · Glia · doi:10.1002/glia.10149 · Cited by 359
Minimal penetration of lipopolysaccharide across the murine blood–brain barrier
Banks, W. A., & Robinson, S. M. (2010) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2009.09.001 · Cited by 356 · cited 4×
“Minocycline readily crosses the BBB and attenuates inflammation associated with microglial activation (45, 59).”
BackgroundInfluentialSerum amyloid A induces IL-8 secretion through a G protein–coupled receptor, FPRL1/LXA4R
He, R., Sang, H., & Ye, R. D. (2003) · Blood · doi:10.1182/blood-2002-05-1431 · Cited by 329
Molecular and cellular immune mediators of neuroprotection
Turrin, N. P., & Rivest, S. (2006) · Molecular Neurobiology · doi:10.1385/mn:34:3:221 · Cited by 85 · cited 2×
“In the brain, LPS activates microglia and astrocytes through the TLR group of pattern recognition receptors, which subsequently activates additional signaling pathways through the adaptor protein MyD88 (36).”
Background
Cited by
COVID-19 immune features revealed by a large-scale single-cell transcriptome atlas
Ren, X., Wen, W., Fan, X., Hou, W., Su, B., Cai, P., Li, J., Liu, Y., Tang, F., Zhang, F., et al. (2021) · Cell · doi:10.1016/j.cell.2021.01.053 · Cited by 865
Sugimoto, M. A., Vago, J. P., Teixeira, M. M., & Sousa, L. P. (2016) · Journal of Immunology Research · doi:10.1155/2016/8239258 · Cited by 414
Sepsis-Associated Encephalopathy and Blood-Brain Barrier Dysfunction
Gao, Q., & Hernandes, M. S. (2021) · Inflammation · doi:10.1007/s10753-021-01501-3 · Cited by 257
Inhibition of formyl peptide receptors improves the outcome in a mouse model of Alzheimer disease
Schröder, N., Schaffrath, A., Welter, J. A., Putzka, T., Griep, A., Ziegler, P., Brandt, E., Samer, S., Heneka, M. T., Kaddatz, H., et al. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01816-2 · Cited by 43
Buss, N. A. P. S., Gavins, F. N. E., Cover, P. O., Terron, A., & Buckingham, J. C. (2015) · The FASEB Journal · doi:10.1096/fj.14-268375 · Cited by 23
Self-citation
Metadata
- Authors
- Gavins, F. N. E., Hughes, E. L., Buss, N. A. P. S., Holloway, P. M., Getting, S. J., & Buckingham, J. C.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2012-09-10
- Volume
- 26
- Issue
- 12
- Pages
- 4977-4989
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2041794020
- Cited by
- 74
- References
- 9
- FWCI
- 1.97
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.